Clinical Trial

Single vs Hypofractionated Irradiation For Timely Access to Partial Breast Radiotherapy

Recruiting
View on ClinicalTrials.gov →
Summary
Partial Breast Irradiation (PBI) is a targeted radiation approach commonly administered post-lumpectomy, specifically targeting the tumour bed. This targeted therapy reduces the exposure to other nearby tissues such as lungs, heart, and chest wall. However, traditional PBI treatment involves lengthy multiple fraction courses which presents a burden to patients from rural and remote communities, who must travel long distances to receive high quality cancer care. The purpose of this study is to compare single fraction (SF) PBI vs. multiple fraction (MF) PBI.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2025-03-14; most recent amendment 2026-06-18.
Status change: Not Yet Recruiting → Recruiting 2026-06-08
Trial Details
NCT Number NCT06885671
Lead Sponsor British Columbia Cancer Agency
Conditions Breast Cancer Early Stage Breast Cancer (Stage 1-3)
Enrollment 60 participants
Start Date 2026-06-08
Primary Completion 2029-12-31 (estimated)
Study Completion 2029-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-06-23